Ghana vs Jordan: Previously treated cases tested for RR-/MDR-TB
Ghana
100.0%
in 2024
Jordan
100.0%
in 2024
Ghana rank
1st
Jordan rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Ghana
- Jordan
How they compare
Ghana currently reports 100.0% against 100.0% in Jordan, a difference of 0.0%.
The two have swapped places 6 times across 17 shared years of data; in 2005 it was Jordan ahead.
Ghana ranks 1st and Jordan ranks 1st of 180 countries.
Across the 3 decades both report, Ghana averaged higher in 2 and Jordan in 1.
Head to head by decade
| Decade | Ghana | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.7% | 100.0% | 93.3% | Jordan |
| 2010s | 68.2% | 36.5% | 31.7% | Ghana |
| 2020s | 98.6% | 58.4% | 40.2% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Ghana or Jordan?
- Ghana, at 100.0% against 100.0% in Jordan as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Ghana and Jordan?
- 0.0%, with Ghana ahead.
- How many years of comparable data are there for Ghana and Jordan?
- 17 years are reported by both, from 2005 to 2024.
- How do Ghana and Jordan rank globally for previously treated cases tested for rr-/mdr-tb?
- Ghana ranks 1st and Jordan ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.